Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    PFEIFFER SYNDROME
Show Display Options
Rank Status Study
1 Terminated Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Condition: Medical Oncology
Intervention: Drug: BAY1187982
2 Active, not recruiting A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Condition: Advanced Cholangiocarcinoma
Intervention: Drug: BGJ398
3 Recruiting Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Condition: Solid Tumor
Intervention: Drug: ARQ 087
4 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib

Indicates status has not been verified in more than two years